MASTER CLASS SERIES
Guidance from Top Industry Experts
Learn from the best.
Industry specialists from across the nation lead master classes designed to take your organization to the next level.
Each series gives you practical ideas and actions to improve your organization. You’ll also gain access to a master educator to answer your questions at each live session. Can’t attend live classes? On-demand sessions will be available at the conclusion of the live series.
Live Virtual Classes
Navigating Pharmaceutical Compounding: A 5-Part Journey Through the History, Evolution, and Future of the Industry
$499
This five-part series of master classes aims to provide a comprehensive understanding of the current state and future direction of the pharmaceutical compounding industry, addressing both historical context and contemporary issues. Join us as we discuss various aspects of industry evolution, regulatory changes, and practical challenges in this exciting series with experts in the pharmaceutical world!
Live virtual classes are scheduled on select Wednesdays, October–December 2024. One CE is available for each class.
Designed for Your Busy Schedule
Each class includes a presentation and Q&A session. Attend live or view recordings of each session at your convenience. Access to on-demand classes will be available at the conclusion of each session.
Taught by Jon Pritchett, Pharm.D., RPh., BCSCP, FAPC, COO of Revelation Pharma
Guest Speakers include: Bryan Prince, Nancy Fingerhut, Shawn Crane, and Shawn Hodges
Dr. Pritchett serves as the Chief Operating Officer (COO), and is responsible for leading and managing all operational activities for Revelation Pharma.
Class 1 | Noon to 1 p.m. ET Wednesday, October 23, 2024
Evolution of the Compounding Industry
Presenter: Jon Pritchett
Overview: This presentation provides a historical overview of the pharmaceutical compounding industry. It will cover the origins, key milestones, and turning points that have shaped modern compounding practices. This session aims to establish foundational concepts for the subsequent topics in the series.
Class 2 | Noon to 1 p.m. ET Wednesday, November 6, 2024
USP Changes: Real-World Implications and Experiences
Presenters: Jon Pritchett and Nancy Fingerhut
Overview: This discussion will center on the impact of USP standards on compounding practices, focusing on the challenges and opportunities presented by the implementation of new versions of USP <795> and <797>. Real-life experiences and practical solutions for adapting to these regulatory changes will be shared.
Class 3 | Noon to 1 p.m. ET Wednesday, November 20, 2024
BUDs Under the New USP Paradigm
Presenters: Jon Pritchett and Nancy Fingerhut
Overview: This presentation will explore the effects of new Beyond-Use Date (BUD) guidelines under USP <795> and <797>. Topics will include the impact on legacy products, process development for compliance, and the role of stability testing in maintaining patient access to compounded medications.
Class 4 | Noon to 1 p.m. ET Wednesday, December 4, 2024
Processes and Challenges in Making Facility Updates to Comply with New Expectations
Presenters: Jon Pritchett, Bryan Prince, and Shawn Crane
Overview: The focus here is on the practical challenges of updating compounding facilities to meet USP Chapters <795>, <797>, and <800> standards. This discussion will cover facility design considerations, potential pitfalls from concept to completion, and real-world experiences to guide compounding pharmacies through the compliance process.
Class 5 | Noon to 1 p.m. ET Wednesday, December 18, 2024
Role of the 503B in the Future of Drug Compounding
Presenters: Jon Pritchett and Shawn Hodges
Overview: This presentation will address the role of 503B outsourcing facilities established under section 503B of the Drug Quality and Security Act. It will review the history and evolution of 503B facilities, their challenges, and the future interplay between 503B and 503A pharmacies to ensure continued patient access to compounded medications.
